Publication: 3144

Publication: 3144

Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer vol 127 (2) 300-9

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 10

Parents:: 2948
Children:: None

Program:: CCP
Primary Committee:: Health Outcomes
Sec. Committees:: Symptom Inter

Pharmas:
Grants:: UG1CA189823, UG1CA189860, UG1CA189817, UG1CA189819, U10CA180790, U10CA180836, U10CA180850, P30CA033572, UL1TR001409

Corr. Author:
Authors:: Michelle J. Naughton Heshan Liu Drew Seisler Jennifer Le-Rademacher Jane M. Armer Jill M. Oliveri Jeffrey A. Sloan Karen Hock Michael Schwartz Gary Unzeitig Marianne Melnik Lisa D. Yee Gini F. Fleming John R. Taylor Charles Loprinzi Electra D. Paskett

Networks:: CA043, CRCWM, LAPS-IL057, LAPS-MN026, LAPS-OH007, MO036, NY213, TX190

Study: CALGB-70305
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: